Related Experiment Video

Updated: May 18, 2026

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering

Linlin Li1, Wenqiang Cao, Wenjie Zheng

  • 1Department of Chemistry, Jinan University, Guangzhou 510632, P. R. China.

Dalton Transactions (Cambridge, England : 2003)
|September 13, 2012
PubMed

Insights

Ruthenium complex RuBmP induces cancer cell death by damaging DNA and activating p53. This novel anticancer agent triggers apoptosis through a DNA damage-mediated pathway, offering a promising therapeutic strategy.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Biochemistry

Background:

  • DNA is a key target for anticancer drug development.
  • Ruthenium complexes show promise as chemotherapeutic agents.
  • Previous work identified RuBmP as an apoptosis-inducer via ROS overproduction.

Purpose of the Study:

  • Elucidate the anticancer mechanisms of RuBmP.
  • Investigate RuBmP's DNA interaction properties.
  • Identify the signaling pathways regulated by RuBmP.

Main Methods:

  • Cellular internalization and DNA strand break assays in A375 cells.
  • Western blotting to assess Histone H2A.X and p53 phosphorylation.
  • Analysis of apoptosis-related proteins (Bcl-xL, caspases, PARP).
  • Spectroscopic and viscosity measurements for DNA binding characterization.

Main Results:

  • RuBmP induced dose-dependent DNA strand breaks in A375 cells.
  • Up-regulation of phosphorylated Histone H2A.X and p53.
  • Inhibition of Bcl-xL, activation of caspases (-3, -8, -9), and PARP cleavage.
  • RuBmP demonstrated intercalative binding to DNA.

Conclusions:

  • RuBmP induces cancer cell apoptosis via DNA damage.
  • The mechanism involves p53 phosphorylation and activation of the intrinsic and extrinsic apoptotic pathways.
  • RuBmP exhibits intercalative DNA binding, supporting its role as an anticancer agent.

More Related Videos

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Published on: March 18, 2015

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...